0 1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z Æ Ø Å
Ønsker du salgsvekst?
B2B Connect er en plattform hvor bedrifter som trenger salgsmøter kan benytte seg av så mange profesjonelle møtebookere de ønsker, fra en stor pool.
Du betaler kun per booket (og gjennomført) salgsmøte, og pris per salgsmøte bestemmer du selv. Det er ingen bindinger, og ingen oppstarts- eller abonnementsavgift. Prøve oss med kun 3 møter?
Navn | Erik Rosen |
---|---|
Orgnr/født år | 1964 |
Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
---|---|---|---|---|---|---|
Ananda AS | 92,000 | 92.0% | 0 | -13 | 910 | 3 |
Snøtindene AS | 20,000 | 50.0% | 0 | -5 | 54 | 2 |
Prosa Security AS | 132,120 | 20.1% | 313 | -89 | 35 | 9 |
Affin AS | 110,000 | 3.9% | 2 | -37 | 27 | 7 |
Polypure AS | 39,567 | 3.2% | 304 | -299 | 456 | 76 |
Bittelille AS | 300 | 1.0% | 1 | -1 | 21 | 2 |
Comlight AS | 40,000 | 0.3% | 13 | -9 | 20 | 25 |
Amicoat AS | 26,751 | 0.1% | 16 | -4 | 49 | 311 |
Advokatguiden AS | 20 | 0.0% | 0 | -1 | -1 | 73 |
Lytix Biopharma AS | 2,630 | 0.0% | 0 | -6 | 3 | 1,097 |
Pharmasum Therapeutics AS | 142 | 0.0% | 0 | -0 | 0 | 683 |
Pharma Holdings AS | 30 | 0.0% | 0 | -0 | 0 | 291 |
* Justert for eierandel
Navn | Ant aksjer | Andel | Omsetning* | Driftsresultat* | Egenkapital* | Ant.eiere |
---|---|---|---|---|---|---|
Changetech AS
Via Ananda AS |
37,178 | 8.5% | 279 | -40 | -455 | 19 |
Bill Kill AS
Via Ananda AS |
69,439 | 3.7% | 305 | -71 | 41 | 118 |
Halibut Arctic Capital AS
Via Ananda AS |
39 | 3.4% | -7 | 498 | 13 | |
Polypure AS
Via Ananda AS |
36,800 | 3.0% | 282 | -278 | 424 | 76 |
Changetech AS
Via Polypure AS |
2,541 | 0.6% | 19 | -3 | -31 | 19 |
Comlight Sales AS
Via Comlight AS |
324 | 0.3% | 13 | 5 | 6 | 1 |
Polypure AS
Via Snøtindene AS |
1,897 | 0.2% | 15 | -14 | 22 | 76 |
Visuado AS
Via Bittelille AS |
107 | 0.1% | 5 | -25 | 19 | 36 |
Amicoat AS
Via Ananda AS |
19,516 | 0.1% | 11 | -3 | 36 | 311 |
Mosshydro AS
Via Ananda AS |
35 | 0.0% | 9 | -0 | 9 | 10 |
Peptide Patents AS
Via Amicoat AS |
0 | 0.0% | 0 | -0 | 0 | 2 |
Amicoat AS
Via Snøtindene AS |
12,876 | 0.0% | 7 | -2 | 24 | 311 |
R-Venture AS
Via Snøtindene AS |
15,500 | 0.0% | -1 | 28 | 220 | |
Lytix Biopharma AS
Via Ananda AS |
10,083 | 0.0% | 1 | -24 | 13 | 1,097 |
Lift Ocean AS
Via Bittelille AS |
60 | 0.0% | 0 | -2 | 4 | 31 |
Pharmasum Therapeutics AS
Via Ananda AS |
538 | 0.0% | 0 | -0 | 0 | 683 |
Pharma Holdings AS
Via Ananda AS |
114 | 0.0% | 0 | -2 | 2 | 291 |
Lytix Biopharma AS
Via Snøtindene AS |
640 | 0.0% | 0 | -2 | 1 | 1,097 |
Peptide Patents AS | 0 | 0.0% | 0 | -0 | 0 | 2 |
Pharmasum Therapeutics AS
Via Snøtindene AS |
36 | 0.0% | 0 | -0 | 0 | 683 |
Pharma Holdings AS
Via Snøtindene AS |
8 | 0.0% | 0 | -0 | 0 | 291 |
Pharmasum Therapeutics AS | 2 | 0.0% | 0 | -0 | 0 | 683 |
* Justert for eierandel